[177] An analysis of events in the US FDA Adverse Event Reporting System suggests an association between several GLP-1 agonists (including semaglutide) and cutaneous reactions, such as dermal hypersensitivity reactions, eosinophilic panniculitis, bullous pemphigoid, and morbilliform drug eruptions
After working with hundreds of people on GLP-1 medications, I've seen the pattern: those who succeed long-term aren't just taking their medication
This may lead to some overestimation of the eligible population of patients without diabetes, though the overweight/obese population of patients without diabetes remains substantial regardless
Patients should not follow online stacking protocols without qualified medical supervision
Fibre, calcium and iron can dip if portions shrink
Why Is Vitamin C Combined with Glutathione